CommuniTreat

CommuniTreat introduces an IP-backed, bio-formula solution to safely and effectively limit overpopulated species harming our environment. Our solution is designed to significantly mitigate ecological and public health risks by positioning fertility control of invasive and feral species as the cornerstone of integrated pest management. Traditional methods alone have been insufficient in reducing rodent overpopulation causing millions of dollars in global damages annually—affecting public health, infrastructure, agriculture, and biodiversity. Through CommuniTreat’s advanced fertility management application (food-based contraceptive), we plan on reducing the reproductive rate of feral and invasive species, helping to restore and maintain the balance between human-animal interactions. CommuniTreat is a part of Treat Group.

CommuniTreat was founded in 2021 by Nimrod Dahan (CEO), Itay Ben Mordechai (Co-founder & Business Development), Dr. Tami Ehrmann Barr (CSO), Dr. Hilik Marom (CVO).

CommuniTreat operates in Agriculture & Food Technologies, Ag Tech, Precision Ag, Health Tech & Life Sciences, Pharma & Medical Biotechnology, with core technologies in Materials & Substances, Biologicals, Herbals. Target customers: Healthcare & Life Sciences, Life Sciences, Transportation & Logistics, Logistics, Energy, Utilities & Waste Management, Government & City, Agriculture & Food, Crops, Processed Foods, Commerce & Retail, Distribution Channels, Industrial Manufacturing, Manufacturing Facilities, Food Retail & Consumption.

CommuniTreat is based in HaPelech St 7, Tel Aviv-Yafo, 6816727, Israel, Center District.